NeuraLight
AI-driven Platform for Digitizing Neurology
StartupNeuraLight is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2021. AI-driven Platform for Digitizing Neurology. The company has raised a total of $30.5M across 2 funding rounds, currently at the A stage. NeuraLight was founded by Gil Shklarski , Micha Breakstone, Edmund Benami. Key investors include Koch Disruptive Technologies, Samsung Next TLV, Chris Mansi, among 9 total investors. The company has 11-50 employees. Core technologies: Platforms & Interfaces, Software, Artificial Intelligence, Computer Vision, Deep Learning.
With $30.5M in total funding, NeuraLight is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial.
- StageA
- ProductClinical Trial
- ModelB2B
- Employees11-50
- HQTel Aviv-Yafo
- DistrictCenter District
- Last Round$25M
- Koch Disruptive TechnologiesLead
- Samsung Next TLV
- Chris Mansi
9 investors total
Gil Shklarski Scientific Co-founder & Board Observer
Micha BreakstoneCo-founder & CEO
Edmund BenamiCo-founder & CTO
8 articles covered by sources including www.medicaldevice-network.com,
www.fastcompany.com,
www.calcalistech.com,
www.geektime.com,
www.israel21c.org.
What does NeuraLight do?
NeuraLight is building an AI-driven platform to accelerate and improve drug development, monitoring, and care for patients with neurological disorders by using information captured with a standard smartphone or webcam. The companys platform automatically extracts micro-oculometrics, providing objective and sensitive digital markers for neurological disorders. The solution is designed to serve as a robust proxy for currently used endpoints and to ultimately define a new measurement standard, paving the path for precision medicine in neurology. NeuraLight is focused on transforming the lives of the billions of people impacted by neurological disorders by digitizing patient evaluation and care. Its vision is a world where neurological disorders can be prevented, diagnosed, and treated effectively so that people can live longer, healthier lives.
How much funding has NeuraLight raised?
NeuraLight has raised $30.5M in total funding across 2 rounds. The company is currently at the A stage. Key investors include Koch Disruptive Technologies, Samsung Next TLV, Chris Mansi.
Who founded NeuraLight?
NeuraLight was founded in 2021 by Gil Shklarski (Scientific Co-founder & Board Observer), Micha Breakstone (Co-founder & CEO), Edmund Benami (Co-founder & CTO).
What sector is NeuraLight in?
NeuraLight operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Platforms & Interfaces, Software, Artificial Intelligence, Computer Vision, Deep Learning. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Healthcare, Providers.
Where is NeuraLight located?
NeuraLight is based in Tel Aviv, Israel, Center District.